title: Malignant neoplasms in cyclosporin A-induced autoimmunity (CyA-AI).
abstract: Lethally X-irradiated LEW rats reconstituted with syngeneic bone marrow and given low-dose Cyclosporine A (CyA) for 5 weeks develop, after withdrawal of CyA, symptoms of disease resembling graft-vs.-host disease (GVHD) as seen after allogeneic bone-marrow transplantation. Symptoms of disease may include acute dermatitis and chronic disease resembling scleroderma. Since anti-class II MHC cytotoxic lymphocytes are generated in this model, it has been proposed as an anti-tumor regimen in humans. We now report that LEW rats treated according to this protocol may, after cessation of CyA administration, paradoxically develop malignant neoplasms. Of 48 experimental animals, 31 developed rapidly progressive subcutaneous and/or intracutaneous tumors commencing at 6 weeks, 13 weeks and 6 months after cessation of CyA. Tumors were of mesenchymal origin, usually high-grade sarcoma, adenocarcinoma or both mesenchymal and epithelial tumors. Such tumor incidence exceeded the incidence of tumor growth in X-irradiated controls, and in rats subjected to thymectomy prior to X-irradiation and CyA administration. CyA by itself induced no tumors. Our results show that total body X-irradiation is required for tumor development but that the presence of CyA-induced autoimmune disease increases the incidence significantly.
authors.affiliation: Department of Immunology, Maastricht University, The Netherlands.
authors.forename: K W
authors.initials: KW
authors.lastname: Wodzig
authors.forename: L J
authors.initials: LJ
authors.lastname: Beijleveld
authors.forename: J G
authors.initials: JG
authors.lastname: Damoiseaux
authors.forename: J W
authors.initials: JW
authors.lastname: Arends
authors.forename: P J
authors.initials: PJ
authors.lastname: van Breda Vriesman
mesh_terms: D000505:Alopecia / Q000276:immunology; D000818:Animals; D015551:Autoimmunity; D016026:Bone Marrow Transplantation; D016572:Cyclosporine; D004848:Epithelium / Q000473:pathology; D005260:Female; D000949:Histocompatibility Antigens Class II / Q000276:immunology; D007150:Immunohistochemistry; D008648:Mesoderm / Q000473:pathology; D009374:Neoplasms, Experimental / Q000276:immunology* / Q000473:pathology; D051381:Rats; D011917:Rats, Inbred Lew; D013047:Specific Pathogen-Free Organisms; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology / Q000473:pathology; D013934:Thymectomy; D014965:X-Rays
chemical_list: D000949:Histocompatibility Antigens Class II; D016572:Cyclosporine